China Investigates Reports of H.I.V.-Tainted Blood Plasma Treatment
BEIJING — Officials in Shanghai are investigating reports that a Chinese pharmaceutical company may have sold more than 12,000 units of a blood plasma product contaminated with H.I.V., potentially the latest in a series of scandals that have threatened to undermine public trust in China’s medical institutions and health care system. In a statement on…
Details